G1 Therapeutics Inc (GTHX)
4.125
+0.36
(+9.42%)
USD |
NASDAQ |
May 01, 16:00
4.125
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Cash and Short Term Investments (Quarterly): 82.16M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.16M |
| September 30, 2023 | 94.35M |
| June 30, 2023 | 104.23M |
| March 31, 2023 | 116.32M |
| December 31, 2022 | 145.07M |
| September 30, 2022 | 122.98M |
| June 30, 2022 | 143.96M |
| March 31, 2022 | 183.02M |
| December 31, 2021 | 221.19M |
| September 30, 2021 | 212.09M |
| June 30, 2021 | 244.02M |
| March 31, 2021 | 278.97M |
| December 31, 2020 | 207.31M |
| September 30, 2020 | 238.34M |
| June 30, 2020 | 234.27M |
| Date | Value |
|---|---|
| March 31, 2020 | 242.40M |
| December 31, 2019 | 269.21M |
| September 30, 2019 | 299.93M |
| June 30, 2019 | 324.91M |
| March 31, 2019 | 347.80M |
| December 31, 2018 | 369.29M |
| September 30, 2018 | 390.52M |
| June 30, 2018 | 188.23M |
| March 31, 2018 | 194.39M |
| December 31, 2017 | 103.81M |
| September 30, 2017 | 118.38M |
| June 30, 2017 | 132.68M |
| March 31, 2017 | 37.73M |
| December 31, 2016 | 47.30M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
82.16M
Minimum
Dec 2023
324.91M
Maximum
Jun 2019
198.14M
Average
212.09M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 286.20M |
| Geron Corp | 333.70M |
| Palatin Technologies Inc | 9.485M |
| Oragenics Inc | 3.484M |
| TG Therapeutics Inc | 217.51M |